Stephen H. Rusckowski served as the CEO and President of Quest Diagnostics from May 2012 until November 2022. He took charge during a crucial time for the company, steering it through the pandemic while maintaining a focus on diagnostics. Under...

Stephen H. Rusckowski served as the CEO and President of Quest Diagnostics from May 2012 until November 2022. He took charge during a crucial time for the company, steering it through the pandemic while maintaining a focus on diagnostics. Under his leadership, Quest achieved record revenues of $10.8 billion and a 27% increase in adjusted earnings per share in 2021. Rusckowski was known for being hands-on in strategic growth, emphasizing acquisitions and improving customer experiences. He also managed to navigate the company’s success despite fluctuating COVID-19 testing demands. Before joining Quest, he was the CEO of two other companies, bringing over 30 years of experience to the diagnostics industry. His approach was straightforward: align executive interests with those of the shareholders and motivate a strong performance-driven culture. His total compensation for 2022 amounted to over $15 million, with a significant portion coming from vested stocks and options, which showcases his confidence in the company’s future. Stephen has also been actively involved in maintaining strong relationships with major health insurance providers, which has been key to Quest's strategy. After his CEO tenure, he continued with Quest as Executive Chairman until March 2023, ensuring a smooth transition for his successor. Rusckowski's role was pivotal in shaping Quest's reputation as a leader in the diagnostics field.